Cargando…

Profile of patients receiving medical care at a reference, support, and treatment center for psoriasis patients at a university hospital

Psoriasis is a chronic, inflammatory, immune-mediated disease affecting 1-3% of the population worldwide. This work seeks to draw a profile of patients with psoriasis, analyzing socioeconomic, anthropometric, and clinical aspects. For this, medical records from 81 individuals who received medical ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cordeiro Júnior, Túlio Germano Machado, Andrade, Bruno D' Paula, Palitot, Esther Bastos, Piuvezam, Márcia Regina, Mascarenhas, Sandra Rodrigues
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Dermatologia 2016
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087241/ https://www.ncbi.nlm.nih.gov/pubmed/27828656 http://dx.doi.org/10.1590/abd1806-4841.201644945

Ejemplares similares

Toxoplasmosis in a patient receiving ixekizumab for psoriasis
por: Lobo, Yolanka, et al.
Publicado: (2020)

PsAPASH: a rare and recent autoinflammatory syndrome associated with hidradenitis suppurativa()()
por: Gadelha, Raissa de Lima, et al.
Publicado: (2020)

Anti-Allergic Properties of Curine, a Bisbenzylisoquinoline Alkaloid
por: Ribeiro-Filho, Jaime, et al.
Publicado: (2015)

Infections in Patients Receiving Subcutaneous Biological Treatments for Moderate to Severe Psoriasis
por: Messori, Andrea, et al.
Publicado: (2015)

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis
por: Mastorino, Luca, et al.
Publicado: (2022)

Paradoxical eczema in patients with psoriasis receiving biologics: a case series
por: Al‐Janabi, Ali, et al.
Publicado: (2022)

IgA nephropathy in a patient receiving infliximab for generalized pustular psoriasis
por: Segawa, Yuka, et al.
Publicado: (2020)

Should all patients with psoriasis receive statins? Analysis according to different strategies()()
por: Masson, Walter, et al.
Publicado: (2019)

Improving management of psoriasis patients receiving biological treatment: A qualitative approach
por: Trettin, Bettina, et al.
Publicado: (2021)

New-onset systemic lupus erythematous in a patient receiving risankizumab for psoriasis
por: Barber, Cara, et al.
Publicado: (2022)

Anti-inflammatory and Antinociceptive Activity of Ouabain in Mice
por: de Vasconcelos, Danielle Ingrid Bezerra, et al.
Publicado: (2011)

A Case of Kaposi's Varicelliform Eruption in a Patient with Psoriasis Receiving Cyclosporine Therapy
por: Külcü Çakmak, Seray, et al.
Publicado: (2015)

Sociodemographic and Clinical Characteristics of Geriatric Patients with Psoriasis Receiving Narrowband Ultraviolet B Phototherapy
por: Legiawati, Lili, et al.
Publicado: (2020)

Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs
por: Gisondi, Paolo, et al.
Publicado: (2021)

COVID-19 Knowledge in Patients with Psoriasis Receiving Systemic Therapy: a Questionnaire Study
por: Özçelik, Sinan, et al.
Publicado: (2022)

Bounded integer model‐based analysis of psoriasis area and severity index in patients with moderate‐to‐severe plaque psoriasis receiving BI 730357
por: Ooi, Qing Xi, et al.
Publicado: (2023)

Epidemiology and outcomes of 655 diabetic foot patients in a Brazilian university hospital
por: de Loiola Cisneros, Ligia, et al.
Publicado: (2015)

The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments
por: Gisondi, Paolo, et al.
Publicado: (2020)

Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis
por: Graier, Thomas, et al.
Publicado: (2020)

Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials
por: Smith, Saxon D., et al.
Publicado: (2023)

Improvements in patient‐reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE
por: Papp, K.A., et al.
Publicado: (2015)

Comorbidities and cardiovascular risk factors in patients with psoriasis
por: Baeta, Isabela Guimarães Ribeiro, et al.
Publicado: (2014)

Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study
por: Rungapiromnan, W., et al.
Publicado: (2019)

Sarcoid-like granulomatous reaction in the lung mimicking miliary tuberculosis in a patient receiving adalimumab for psoriasis
por: AKDOĞAN, Neslihan, et al.
Publicado: (2021)

COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study
por: Lodde, Georg Christian, et al.
Publicado: (2023)

Perspective of pediatricians and adolescent patients on the transition process in a university hospital
por: Silva, Luiza Mariana Cordeiro, et al.
Publicado: (2022)

Improvement of Comorbid Psoriasis in Patients With MS Treated With Natalizumab
por: Berkovich, Regina, et al.
Publicado: (2021)

Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis
por: Luna, Paula C., et al.
Publicado: (2023)

Outcomes of COVID-19 Infection in Patients Receiving Ruxolitinib and Hypomethylating Agent Therapy
por: Nathan, Daniel I., et al.
Publicado: (2020)

Measles, rubella, mumps and Toxoplasma gondii antibodies in saliva of vaccinated students of schools and universities in São Paulo City, Brazil
por: Sampaio, Barbara Carvalho Fialho, et al.
Publicado: (2019)

Displacement of Hyaluronic Acid Dermal Filler Mimicking a Cutaneous Tumor: A Case Report
por: Magacho-Vieira, Fabiano Nadson, et al.
Publicado: (2023)

Large polyps: Pearls for the referring and receiving endoscopist
por: Markarian, Eric, et al.
Publicado: (2021)

Anti‐asthmatic and anxiolytic effects of Herissantia tiubae, a Brazilian medicinal plant
por: Mozzini Monteiro, Talissa, et al.
Publicado: (2016)

Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy
por: Yiu, Z.Z.N., et al.
Publicado: (2019)

Risk of herpes zoster in psoriasis patients receiving systemic therapies: a nationwide population-based cohort study
por: Ting, Sze-Wen, et al.
Publicado: (2021)

A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17
por: Armstrong, April W., et al.
Publicado: (2022)

Evaluation of Serum Creatinine Levels with Reference Change Value in Patients Receiving Colistin Treatment
por: Cinpolat, Havva Yasemin, et al.
Publicado: (2023)

Prevalence of infection by Bartonella spp. in patients with psoriasis()()
por: Santos, Luciene Silva dos, et al.
Publicado: (2021)

Escitalopram in patients with psoriasis
por: Artemieva, M., et al.
Publicado: (2021)

Characteristics of postintubation dysphagia in ICU patients in the context of the COVID-19 outbreak: A report of 920 cases from a Brazilian reference center
por: Sassi, Fernanda Chiarion, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qeq69hjiu31vf7179lfadolopl